Moreover, xenografts of UCP2-overexpressing HCT116 colon cancer cells retain growth in nude mice receiving chemotherapy, providing strong evidence that UCP2 upregulation is a plausible mechanism of chemoresistance in such studies (Derdak et al, 2008). The gene discussed is UCP2; the disease is colonic neoplasm.